Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fresco Names Former Fitbit Executive, Joanne Savage, as Chief Marketing Officer
-
Philips delivers strong ESG performance in 2023
-
Municipality Finance issues EUR 20 million notes under its MTN programme
-
Ovation Fertility Welcomes Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), as Cincinnati Lab Director
-
Form 8.5 (EPT/RI) - FireAngel Safety Technology Group Plc
-
Kering: Monthly statement on the total number of shares and voting rights (February 2024)
-
Form 8.5 (EPT/RI) - musicMagpie Plc
-
Share buybacks in Spar Nord Bank – transactions in week 7
-
Philips proposes to re-appoint Chairman Feike Sijbesma and Peter Löscher and nominates Benoît Ribadeau-Dumas as member of the Supervisory Board
-
Philips publishes its Annual Report 2023
-
Terranet invites to presentation of year-end report on February 22, 2024
-
Roche Diagnostics and BioPorto expand collaboration
-
Form 8.5 (EPT/RI) - Kin & Carta plc
-
Form 8.5 (EPT/RI) - Abrdn European Logistics Income plc
-
Top US Bank, Commerce goes live with loan origination on Temenos banking platform
-
Prosafe SE: Operational Update - February 2024
-
Sanoma Corporation - Managers' Transactions
-
Equinor ASA: Share buy-back
-
Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results
-
Alliance Trust PLC - Dividend Declaration
-
Irish Residential Properties Sub-Fund 1: Form 8.3 - Irish Residential Properties REIT PLC
-
Holdings in Company
-
Fingerprints and Ansal Component collaborate on biometric access control for Türkiye
-
KBC Group: Update regarding the KBC Group share buyback programme
-
Lleida.net extends its contract with LaLiga EA Sports until 2027 and hires three more services
-
Transaction in Own Shares
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
-
CGG Adds New Southeast Asia Carbon Storage Study to Growing CCUS Library
-
Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma
-
Avance Gas Holding Ltd: Ex Dividend USD 0.65 today
-
Arctic Wolf Threat Report Highlights Sharp Rise in Ransom Demands and BEC Incidents
-
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART Hytrulo in Chronic Inflammatory Demyelinating Polyneuropathy
-
Fujifilm Debuts X100VI Mirrorless Digital Camera
-
Start of Day Message
-
Ensurge Micropower ASA - Q4 2023
-
Pluxee strengthens its Leadership Team
-
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART Hytrulo in Chronic Inflammatory Demyelinating Polyneuropathy
-
Zoomcar and SPARKCARS Forge Transformative Partnership to Raise EV Car Adoption in Self-Drive Space
-
HYW INVESTOR NEWS: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Hywin Holdings Ltd. Investors to Inquire About Securities Class Action Investigation – HYW
-
PSA collaborates with HERE Technologies to optimize truck operations in Singapore
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, Xponential, and Amplitude and Encourages Investors to Contact the Firm
-
ELS INVESTOR NOTICE: NATIONALLY RANKED ROSEN LAW FIRM Encourages Equity LifeStyle Properties, Inc. Investors to Inquire About Securities Class Action Investigation – ELS
-
Goodfellow Reports Its Results for the Fourth Quarter and Fiscal Year Ended November 30, 2023 and Declares a Dividend
-
RENB SHAREHOLDER ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
-
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
-
Porsche presents two new Panamera E-Hybrid variants
-
Lilium partners with PhilJets to bring eVTOLs to Asia, starting with the Philippines
-
Transocean Ltd. Reports Fourth Quarter and Full Year 2023 Results

